TY - JOUR
T1 - American Society of Transplantation and Cellular Therapy Series
T2 - #7 - Management of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients
AU - El Chaer, Firas
AU - Kaul, Daniel R.
AU - Englund, Janet A.
AU - Boeckh, Michael
AU - Batista, Marjorie V.
AU - Seo, Susan K.
AU - Carpenter, Paul A.
AU - Navarro, David
AU - Hirsch, Hans H.
AU - Ison, Michael G.
AU - Papanicolaou, Genovefa A.
AU - Chemaly, Roy F.
N1 - Publisher Copyright:
© 2023 The American Society for Transplantation and Cellular Therapy
PY - 2023/12
Y1 - 2023/12
N2 - The Practice Guidelines Committee of the American Society of Transplantation and Cellular Therapy (ASTCT) partnered with its Transplant Infectious Disease Special Interest Group (TID-SIG) to update the 2009 compendium-style infectious disease guidelines for hematopoietic cell transplantation (HCT). A new approach was adopted to better serve clinical providers by publishing each standalone topic in the infectious disease series in a concise format of frequently asked questions (FAQ), tables, and figures. Experts in HCT and infectious diseases identified FAQs and then provided answers based on the strength of the recommendation and the level of supporting evidence. In the seventh guideline in the series, we focus on the respiratory syncytial virus (RSV) with FAQs addressing epidemiology, clinical diagnosis, prophylaxis, and treatment. Special consideration was given to RSV in pediatric, cord blood, haploidentical, and T cell-depleted HCT and chimeric antigen receptor T cell therapy recipients, as well as to identify future research directions.
AB - The Practice Guidelines Committee of the American Society of Transplantation and Cellular Therapy (ASTCT) partnered with its Transplant Infectious Disease Special Interest Group (TID-SIG) to update the 2009 compendium-style infectious disease guidelines for hematopoietic cell transplantation (HCT). A new approach was adopted to better serve clinical providers by publishing each standalone topic in the infectious disease series in a concise format of frequently asked questions (FAQ), tables, and figures. Experts in HCT and infectious diseases identified FAQs and then provided answers based on the strength of the recommendation and the level of supporting evidence. In the seventh guideline in the series, we focus on the respiratory syncytial virus (RSV) with FAQs addressing epidemiology, clinical diagnosis, prophylaxis, and treatment. Special consideration was given to RSV in pediatric, cord blood, haploidentical, and T cell-depleted HCT and chimeric antigen receptor T cell therapy recipients, as well as to identify future research directions.
KW - Guidelines
KW - Hematopoietic cell transplantation
KW - Respiratory syncytial virus
UR - http://www.scopus.com/inward/record.url?scp=85176283609&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85176283609&partnerID=8YFLogxK
U2 - 10.1016/j.jtct.2023.09.018
DO - 10.1016/j.jtct.2023.09.018
M3 - Article
C2 - 37783338
AN - SCOPUS:85176283609
SN - 2666-6367
VL - 29
SP - 730
EP - 738
JO - Transplantation and Cellular Therapy
JF - Transplantation and Cellular Therapy
IS - 12
ER -